Joint Letter of Support for the MEDS Act
Dear Senator Collins and Senator Smith,
The undersigned organizations are writing in support of S.2723 – The Mitigating Emergency Drug Shortages (MEDS) Act. Drug shortages have been on the rise for several years, with an estimated 210 drugs currently at risk or not readily available for U.S. hospitals, according to the national database maintained by the American Society of Health System Pharmacists (ASHP). The Food and Drug Administration (FDA) also states that drug shortages have grown more persistent since 2014 with many shortages lasting multiple years.
Click here to read the full letter.
Related Posts
HSCA Statement on House Committee on Homeland Security Hearing on the Coronavirus
Washington, DC (March 11, 2020) – Healthcare Supply Chain Association (HSCA)...
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...
HSCA CEO to Lead Panel Discussion on Innovation at AdvaMed’s MedTech Conference
Washington, DC (September 23, 2019) – The Healthcare Supply Chain...
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...